
|Articles|February 1, 1997
Supplements and Featured Publications
- Looking Beyond the Formulary Budget: Cost Analysis and a Psychiatric Perspective
- Volume 3
- Issue 2 Suppl
Evaluating the Cost Effectiveness of Newer Psychotropic Medications
Author(s)Gary L. Viale, PharmD
Advertisement
Articles in this issue
over 28 years ago
Introduction: Looking Beyond the Formulary Budgetover 28 years ago
Looking Beyond the Formulary Budget in Cost-Benefit Analysisover 28 years ago
Newer Antipsychotic Medications: Discussionsover 28 years ago
Bibliographyover 28 years ago
ParticipantsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Abemaciclib Plus Endocrine Therapy Improves Overall Survival in High-Risk Early Breast Cancer
2
Medicare State Rankings Reveal Stark Differences in Access, Quality, and Affordability
3
New Biomarkers, Drug Targets Identified for Colorectal Cancer
4
First-Line Zongertinib Yields Strong Responses in Patients With Advanced HER2-Mutant NSCLC
5